Is Artichoke Cholesterol Meta-Analysis safe?

Updated June 2026

Quick Answer

Artichoke Cholesterol Meta-Analysis has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: 1 2 3 Obesity is a multifactorial disease defined as abnormal or excessive fat accumulation that presents a risk to health because it is a major risk factor for several noncommunicable diseases (NCDs), such as cardiovascular diseases, diabetes, and several types of cancer [].

Key Takeaways

  • 011 2 3 Obesity is a multifactorial disease defined as abnormal or excessive fat accumulation that presents a risk to health because it is a major risk factor for several noncommunicable diseases (NCDs), such as cardiovascular diseases, diabetes, and several types of cancer []. [Pujia Carmelo (2026)]
  • 02Furthermore, obesity and its associated health problems have a significant economic impact on the global healthcare system [,]. [Pujia Carmelo (2026)]
  • 03It is well known that a weight loss of between 5% and 10% is sufficient to achieve clinically significant improvements in health risk factors []. [Pujia Carmelo (2026)]
  • 04It is a major public health concern that has reached pandemic proportions worldwide. [Pujia Carmelo (2026)]
The current Migaku evidence database contains 2 reusable source documents for Artichoke Cholesterol Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts. - 1 2 3 Obesity is a multifactorial disease defined as abnormal or excessive fat accumulation that presents a risk to health because it is a major risk factor for several noncommunicable diseases (NCDs), such as cardiovascular diseases, diabetes, and several types of cancer []. [Pujia Carmelo (2026); evidence level 1] - Furthermore, obesity and its associated health problems have a significant economic impact on the global healthcare system [,]. [Pujia Carmelo (2026); evidence level 1] - It is well known that a weight loss of between 5% and 10% is sufficient to achieve clinically significant improvements in health risk factors []. [Pujia Carmelo (2026); evidence level 1] - It is a major public health concern that has reached pandemic proportions worldwide. [Pujia Carmelo (2026); evidence level 1] - Cardiovascular disease (CVD) remains the leading cause of death worldwide, with elevated low-density lipoprotein cholesterol (LDL-C) as a major risk factor. [Jacobo-Velázquez DA (2025); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Effect of Citrus bergamia Supplementation on Body Composition in Humans: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
  2. Functional Foods for Cholesterol Management: A Review of the Mechanisms, Efficacy, and a Novel Cholesterol-Lowering Capacity Index.